BusinessNovavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017By Nasdaq OMXFeb 20, 2017, 9:05 PM UTC
BusinessNewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017By Nasdaq OMXFeb 20, 2017, 12:00 PM UTC
BusinessAbeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017By Nasdaq OMXFeb 17, 2017, 12:45 PM UTC
BusinessMyriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, OlaparibBy Nasdaq OMXFeb 17, 2017, 12:30 PM UTC
BusinessMyriad’s Prolaris® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate CancerBy Nasdaq OMXFeb 17, 2017, 12:05 PM UTC
BusinessMacroGenics Announces Date of Fourth Quarter and Full Year 2016 Financial Results Conference CallBy Nasdaq OMXFeb 16, 2017, 9:30 PM UTC
BusinessCytokinetics, Inc. Reports Fourth Quarter 2016 Financial ResultsBy Nasdaq OMXFeb 16, 2017, 9:00 PM UTC
BusinessNeos Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare ConferenceBy Nasdaq OMXFeb 16, 2017, 12:30 PM UTC
